Acemannan as a potential therapeutic agent for cognitive impairment via modulation of cholinergic, oxidative, and inflammatory pathways: in vivo and in silico evidence
- DOI
- 10.1007/s13205-026-05068-4
- Published
- 2026-09-18
- Container
- 3 Biotech
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s13205-026-05068-4,
title = {Acemannan as a potential therapeutic agent for cognitive impairment via modulation of cholinergic, oxidative, and inflammatory pathways: in vivo and in silico evidence},
author = {Sami I. Alzarea and Tariq G. Alsahli and Abdulaziz Ibrahim Alzarea and Mashan Almutairi and Ali Alquraini and Ameeduzzafar Zafar and Nadeem Sayyed},
year = {2026},
journal = {3 Biotech},
doi = {10.1007/s13205-026-05068-4},
url = {https://doi.org/10.1007/s13205-026-05068-4}
}RIS
TY - JOUR TI - Acemannan as a potential therapeutic agent for cognitive impairment via modulation of cholinergic, oxidative, and inflammatory pathways: in vivo and in silico evidence AU - Sami I. Alzarea AU - Tariq G. Alsahli AU - Abdulaziz Ibrahim Alzarea AU - Mashan Almutairi AU - Ali Alquraini AU - Ameeduzzafar Zafar AU - Nadeem Sayyed PY - 2026 JO - 3 Biotech DO - 10.1007/s13205-026-05068-4 UR - https://doi.org/10.1007/s13205-026-05068-4 ER -
APA
Alzarea, S. I., Alsahli, T. G., Alzarea, A. I., Almutairi, M., Alquraini, A., Zafar, A., & Sayyed, N. (2026). Acemannan as a potential therapeutic agent for cognitive impairment via modulation of cholinergic, oxidative, and inflammatory pathways: in vivo and in silico evidence. 3 Biotech. https://doi.org/10.1007/s13205-026-05068-4
Source records
- crossref · retrieved 2026-09-25T04:35:39.935Z